Speaking with ANI, Pant said India's GDP growth is currently estimated at 7.4% for the ongoing fiscal year and is likely to moderate to around 6.9% in the next fiscal year. He cautioned, however, that these numbers are subject to revision as the base year for national income accounting will
South Korea's Celltrion Inc. has signed an agreement to acquire Eli Lilly and Company's U.S. biopharmaceutical manufacturing facility, eliminating its tariff-related risks in the U.S. market. The purchase price was USD 330 million, as per a report by Pulse, the English service of Maeil Busi
Despite global headwinds ranging from tariff volatility to geopolitical tensions, NSE's Macro Review report notes that India's GDP momentum could ease over in next few quarters as higher tariffs begin to weigh on exports. At the same time, a possible rationalisation of GST rates ahead of the
South Korean exporters want new government to go for a strategic shift in the trade policy amid U.S. tariff risks, reveals a survey as reported by the Korea Herald.
The BSE Sensex slipped 69.91 points, opening at 76,278.16, while the NSE Nifty declined 22.40 points, starting at 23,168.25. Despite the negative opening, market breadth remained mixed, with 31 Nifty companies advancing and 19 declining.